Trials
Search / Trial NCT06438601

A Clinical Comparison of Two Multifocal Toric Soft Contact Lenses

Launched by COOPERVISION INTERNATIONAL LIMITED (CVIL) · May 30, 2024

Trial Information

Current as of February 18, 2025

Active, not recruiting

Keywords

ClinConnect Summary

The aim of this study is to evaluate the short-term clinical performance of two multifocal toric soft contact lenses after 15 minutes of daily wear each.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. They are aged 35 years or over and have capacity to volunteer.
  • 2. They understand their rights as a subject and are willing to sign a Statement of Informed Consent.
  • 3. They are willing and able to follow the protocol.
  • 4. They agree not to participate in other clinical research for the duration of this study.
  • 5. They are currently wearing soft contact lenses or have done so within the past 12 months.
  • 6. They have a spherical prescription between +10.00 and -10.00DS inclusive, (based on the ocular refraction).
  • 7. They have astigmatism of between -0.75 and -5.75DC (based on the ocular refraction) in each eye.
  • 8. They have a reading addition component to their spectacle refraction of between +0.75 and +2.50DS.
  • 9. They can be satisfactorily fitted with the study lenses.
  • 10. They own a wearable pair of spectacles.
  • Exclusion Criteria:
  • 1. They have an ocular disorder which would normally contraindicate contact lens wear.
  • 2. They have a systemic disorder which would normally contra-indicate contact lens wear.
  • 3. They are using any topical medications such as eye drops or ointment.
  • 4. They have had cataract surgery.
  • 5. They have had corneal refractive surgery.
  • 6. They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.
  • 7. They have any ocular abnormality which would, in the opinion of the investigator, normally contraindicate contact lens wear.
  • 8. They have eye or health conditions including immunosuppressive or infectious diseases which would, in the opinion of the investigator, contraindicate contact lens wear or pose a risk to study personnel; or a history of anaphylaxis or severe allergic reaction.
  • 9. They have taken part in any other contact lens or care solution clinical trial or research, within two weeks prior to starting this study.

Trial Officials

Carole Maldonado-Codina, PhD,MCOptom

Principal Investigator

Eurolens Research

About Coopervision International Limited (Cvil)

CooperVision International Limited (CVIL) is a leading global manufacturer of contact lenses and related products, dedicated to enhancing vision health and improving the quality of life for wearers worldwide. With a strong commitment to innovation and research, CVIL invests in clinical trials to develop advanced lens technologies and solutions tailored to diverse vision needs. The company operates with a focus on safety, efficacy, and customer satisfaction, ensuring that their products meet the highest standards of quality and performance. Through partnerships and collaborations, CVIL continues to drive advancements in the eye care industry while prioritizing patient outcomes and satisfaction.

Locations

Manchester, , United Kingdom

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0